Terashima I, Uehara S, Toba T, Hayashi T, Hoshi M
Jpn J Antibiot. 1984 Nov;37(11):2021-6.
Fundamental and clinical evaluation on ceftriaxone (Ro 13-9904, CTRX) was performed and the following results were obtained. As to bacteriological efficacy, bacteria were reduced in the case with S. panama bacteremia, while they were eradicated within 2 to 5 days after CTRX administration in 2 cases with acute urinary tract infections and 1 with recurrent urinary tract infection, both caused with E. coli, and in 1 with acute urinary tract infection with P. mirabilis. The clinical efficacy was excellent in 2 cases and good in 3, the efficacy rate being 100%. No side effects were observed to require the withdrawal of CTRX.
对头孢曲松(Ro 13-9904,CTRX)进行了基础和临床评估,获得了以下结果。关于细菌学疗效,在巴拿马菌血症病例中细菌数量减少,而在2例由大肠杆菌引起的急性尿路感染和1例复发性尿路感染以及1例由奇异变形杆菌引起的急性尿路感染患者中,在给予CTRX后2至5天内细菌被根除。临床疗效方面,2例为优,3例为良,有效率为100%。未观察到需要停用CTRX的副作用。